Han Xu

1.8k total citations
47 papers, 1.2k citations indexed

About

Han Xu is a scholar working on Molecular Biology, Hematology and Genetics. According to data from OpenAlex, Han Xu has authored 47 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Molecular Biology, 7 papers in Hematology and 5 papers in Genetics. Recurrent topics in Han Xu's work include Platelet Disorders and Treatments (6 papers), Blood Coagulation and Thrombosis Mechanisms (5 papers) and Sphingolipid Metabolism and Signaling (5 papers). Han Xu is often cited by papers focused on Platelet Disorders and Treatments (6 papers), Blood Coagulation and Thrombosis Mechanisms (5 papers) and Sphingolipid Metabolism and Signaling (5 papers). Han Xu collaborates with scholars based in United States, China and Thailand. Han Xu's co-authors include Marvin T. Nieman, Yan Guan, Nongjian Tao, Shaopeng Wang, Hailong Yan, Wei Wang, Yunze Yang, Linliang Yin, Fenni Zhang and Hong Chen and has published in prestigious journals such as Journal of Neuroscience, Blood and Analytical Chemistry.

In The Last Decade

Han Xu

45 papers receiving 1.1k citations

Peers

Countries citing papers authored by Han Xu

Since Specialization

Citations

This map shows the geographic impact of Han Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Han Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Han Xu more than expected).

Fields of papers citing papers by Han Xu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Han Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Han Xu. The network helps show where Han Xu may publish in the future.

Co-authorship network of co-authors of Han Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Han Xu. A scholar is included among the top collaborators of Han Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Han Xu. Han Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Elucidating the dynamics of integrin αIIbβ3 from native platelet membranes by cryo-EM with build-and-retrieve method 2025 ·Blood Advances ·Han Xu, (unknown), Chih‐Chia Su, (unknown), Masaru Miyagi, Edward Yu, Marvin T. Nieman	0
2	The Plasmodium falciparum NCR1 transporter is an antimalarial target that exports cholesterol from the parasite’s plasma membrane 2024 ·Science Advances ·(unknown), (unknown), Han Xu, Sepalika Bandara, Meng Cui, Eva S. Istvan, Xinran Geng, (unknown), (unknown), Masaru Miyagi, Jenna Oberstaller, John H. Adams, (unknown), Marvin T. Nieman, Johannes von Lintig, Daniel E. Goldberg, Edward Yu	1
3	A mouse model of the protease-activated receptor 4 Pro310Leu variant has reduced platelet reactivity 2024 ·Journal of Thrombosis and Haemostasis ·Han Xu, (unknown), (unknown), Wei Li, Ronald A. Conlon, David F. LePage, Weihong Jiang, (unknown), Steven E. McKenzie, Marvin T. Nieman	5
4	Varied cellular abnormalities in thin vs. normal endometrium in recurrent implantation failure by single-cell transcriptomics 2024 ·Reproductive Biology and Endocrinology ·Xiaoying Fu, (unknown), Han Xu, Yini Li, Bihui Jin, (unknown), (unknown), (unknown), Yiqi Yu, Yuqing Tian, (unknown), Shu Jing	5
5	99mTc /SPIO-loaded polymeric micelles as MRI and SPECT imaging, cancer-targeted nanoprobe for liver cancer detection 2022 ·Journal of Drug Delivery Science and Technology ·(unknown), (unknown), (unknown), (unknown), Han Xu, Pinunta Nittayacharn, Marvin T. Nieman, Chanisa Chotipanich, Witaya Sungkarat, Panya Sunintaboon, Agata A. Exner, Norased Nasongkla	4
6	GPR84 Is Essential for the Taste of Medium Chain Saturated Fatty Acids 2021 ·Journal of Neuroscience ·Yan Liu, Han Xu, (unknown), (unknown), Fangjun Lin, Timothy A. Gilbertson	12
7	Intravenous Nanomedicine for Targeted Delivery of Thrombin to Augment Hemostasis 2021 ·Blood ·Anirban Sen Gupta, (unknown), (unknown), María de la Fuente, Han Xu, Marvin T. Nieman, (unknown)	8
8	Complement factor C4a does not activate protease‐activated receptor 1 (PAR1) or PAR4 on human platelets 2020 ·Research and Practice in Thrombosis and Haemostasis ·Han Xu, María de la Fuente, Marvin T. Nieman	7
9	PAR4 activation involves extracellular loop 3 and transmembrane residue Thr153 2020 ·Blood ·Han Xu, Lukas Hofmann, (unknown), Nathan Alexander, Krzysztof Palczewski, Marvin T. Nieman	21
10	Expression and Purification of Protease-Activated Receptor 4 (PAR4) and Analysis with Histidine Hydrogen–Deuterium Exchange 2020 ·Biochemistry ·(unknown), Han Xu, Masaru Miyagi, Marvin T. Nieman	7
11	Protease‐activated receptors: An illustrated review 2020 ·Research and Practice in Thrombosis and Haemostasis ·Han Xu, Marvin T. Nieman, Bryce A. Kerlin	39
12	Parallel Fourier ptychographic microscopy for high-throughput screening with 96 cameras (96 Eyes) 2019 ·Scientific Reports ·Antony C. S. Chan, Jinho Kim, An Pan, Han Xu, Dana Nojima, Christopher M. Hale, Songli Wang, Changhuei Yang	38
13	Bovine pituitary homeobox 2 (PITX2): mRNA expression profiles of different alternatively spliced variants and association analyses with growth traits 2018 ·Gene ·Sihuan Zhang, Han Xu, Zihong Kang, Hanfang Cai, Ruihua Dang, Chuzhao Lei, Hong Chen, Xian Guo, Xianyong Lan	11
14	Comparison of bioactive components and pharmacological activities of ophiopogon japonicas extracts from different geographical origins 2017 ·Journal of Pharmaceutical and Biomedical Analysis ·Min Zhao, Wanfeng Xu, (unknown), (unknown), Jun Zhang, Dandan Wang, Han Xu, Hong Wang, Tingting Yan, Lin Wang, Haiping Hao, Guangji Wang, Lijuan Cao	28
15	Isolation and Characterization of a Distinct Subpopulation from the WM115 Cell Line That Resembles In Vitro Properties of Melanoma Cancer Stem Cells 2017 ·SLAS DISCOVERY ·(unknown), Mark H. Chin, Mark L. Sandberg, Han Xu	3
16	Characterization of the direct interaction between KcsA-Kv1.3 and its inhibitors 2015 ·Biochimica et Biophysica Acta (BBA) - Biomembranes ·Han Xu, John J. Hill, Klaus Michelsen, Harvey Yamane, Robert J. Kurzeja, (unknown), Richard Isaacs, Fei Shen, Philip Tagari	19
17	MicroRNA-24 can control triacylglycerol synthesis in goat mammary epithelial cells by targeting the fatty acid synthase gene 2015 ·Journal of Dairy Science ·Haihua Wang, Jun Luo, (unknown), Wenting Cao, Han Xu, Deming Gou, Jiangjiang Zhu	35
18	Predictability of Peripheral Lymphocyte Reduction of Novel S1P1 Agonists by In Vitro GPCR Signaling Profile 2013 ·SLAS DISCOVERY ·Han Xu, Michele McElvain, Mike Fiorino, (unknown), (unknown), Yang Xu, (unknown), Keith W. Kelley, Matthew Adlam, Roland W. Bürli, (unknown), Min Wong, Victor J. Cee	3
19	Novel 5- and 6-subtituted benzothiazoles with improved physicochemical properties: Potent S1P1 agonists with in vivo lymphocyte-depleting activity 2011 ·Bioorganic & Medicinal Chemistry Letters ·Mike Frohn, Victor J. Cee, Brian A. Lanman, Alexander J. Pickrell, Jennifer E. Golden, Dalia Rivenzon‐Segal, Scot Middleton, Mike Fiorino, Han Xu, Michael Schrag, Yang Xu, Michele McElvain, (unknown), (unknown), Roland W. Bürli	9
20	New ‘chemical probes’ to examine the role of the hFPRL1 (or ALXR) receptor in inflammation 2007 ·Bioorganic & Medicinal Chemistry Letters ·Mike Frohn, Han Xu, Xiaoming Zou, Catherine Chang, (unknown), Matthew Plant, Min Wong, Philip Tagari, Randall W. Hungate, Roland W. Bürli	29

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact